Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein

By Yamada T.   Iwabuki H.   Kanno T.   Tanaka H.   Kawai T.   Fukuda H.   Kondo A.   Seno M.   Tanizawa K.   Kuroda S.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3154-3163

Elsevier

Access to resources Recommend Favorite

Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I

By Kutinova L.   Ludvikova V.   Krystofova J.   Otavova M.   Simonova V.   Nemeckova S.   Hainz P.   Vonka V.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1045-1052

Elsevier

Access to resources Recommend Favorite

Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene(R), a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products

By Pride M.W.   Bailey C.R.   Muchmore E.   Thanavala Y.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 543-550

Elsevier

Access to resources Recommend Favorite

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

By Shen X.   Lagergard T.   Yang Y.   Lindblad M.   Fredriksson M.   Wallerstrom G.   Holmgren J.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3360-3368

Elsevier

Access to resources Recommend Favorite